IDP-126 Meets Endpoints in Second Phase 3 Study
June 16, 2021

IDP-126, an acne vulgaris treatment for patients ages 9 and older, met all of its endpoints in a 12-week phase 3 study.

AAD Tackles Tough Issues in Upcoming Acne Update
June 16, 2021

American Academy of Dermatology’s updated guidelines on acne will cover dermatology’s hottest issues, from dosing and monitoring established medications to exploring new antibiotics and addressing antibiotic stewardship.

What’s New in Acne and Rosacea for 2021?
June 15, 2021

Emmy Graber, MD, presented the updates in acne and rosacea treatments at the SCALE Acne and Rosacea update on June 9, 2021.